- Home
- TCGL vs SRZN Comparison
TCGL vs SRZN Comparison
Compare TCGL & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCGL
- SRZN
- Stock Information
- Founded
- TCGL 2015
- SRZN 2015
- Country
- TCGL Singapore
- SRZN United States
- Employees
- TCGL N/A
- SRZN N/A
- Industry
- TCGL EDP Services
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- TCGL Technology
- SRZN Health Care
- Exchange
- TCGL Nasdaq
- SRZN Nasdaq
- Market Cap
- TCGL 85.6M
- SRZN 97.3M
- IPO Year
- TCGL 2025
- SRZN N/A
- Fundamental
- Price
- TCGL $4.62
- SRZN $13.71
- Analyst Decision
- TCGL
- SRZN Strong Buy
- Analyst Count
- TCGL 0
- SRZN 2
- Target Price
- TCGL N/A
- SRZN $38.50
- AVG Volume (30 Days)
- TCGL 670.4K
- SRZN 30.2K
- Earning Date
- TCGL 11-16-2025
- SRZN 11-07-2025
- Dividend Yield
- TCGL N/A
- SRZN N/A
- EPS Growth
- TCGL N/A
- SRZN N/A
- EPS
- TCGL N/A
- SRZN N/A
- Revenue
- TCGL $2,274,647.00
- SRZN $12,621,000.00
- Revenue This Year
- TCGL N/A
- SRZN N/A
- Revenue Next Year
- TCGL N/A
- SRZN N/A
- P/E Ratio
- TCGL N/A
- SRZN N/A
- Revenue Growth
- TCGL 7.80
- SRZN N/A
- 52 Week Low
- TCGL $3.95
- SRZN $5.90
- 52 Week High
- TCGL $5.43
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- TCGL N/A
- SRZN 60.58
- Support Level
- TCGL N/A
- SRZN $13.14
- Resistance Level
- TCGL N/A
- SRZN $14.40
- Average True Range (ATR)
- TCGL 0.00
- SRZN 0.45
- MACD
- TCGL 0.00
- SRZN -0.08
- Stochastic Oscillator
- TCGL 0.00
- SRZN 29.43
About TCGL TechCreate Group Ltd. Class A Ordinary Shares
TechCreate Group Ltd is a technology consultancy and advanced software solution provider offering a comprehensive range of payment, cybersecurity, and digital services and solutions. It serves large institutions, financial institutions and telecommunication companies, by providing them with payment, cybersecurity, and digital solutions such as, the development of RTE, RTP, API management and other services, such as cybersecurity defense, IT infrastructure, and cloud services. Its core business areas comprise: (1) the provision of professional services, (2) the sale of software licenses and maintenance licenses, and (3) the sale of hardware solutions.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).